Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 18,460 shares at $73.18 ($1.3M) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Scheduled sale ($1.3M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.18 | 2,000 | $146K | 10.9% |
| 2 | $72.74 | 8,230 | $599K | 44.6% |
| 3 | $72.74 | 8,230 | $599K | 44.6% |
| Total | $72.79 avg | 18,460 | $1.3M | 100% |
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |